Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of Anemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00558454
What this trial is testing

Iron Supplementation of Marginally Low Birth Weight Infants

Who this might be right for
AnemiaIron-DeficiencyChild Behavior Disorders+1 more
Umeå University 380
Testing effectiveness (Phase 2)Study completedNCT00402480
What this trial is testing

Hydroxyurea to Prevent Stroke in Children With Sickle Cell Anemia and Elevated TCD Flow Velocity

Who this might be right for
Stroke
Duke University 50
Not applicableUnknownNCT02474420
What this trial is testing

Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients

Who this might be right for
Beta-ThalassemiaIron Overload
Kevin H.M. Kuo, MD, MSc, FRCPC 60
Not applicableStudy completedNCT02484274
What this trial is testing

Iron Deficiency (ID) in Infants

Who this might be right for
Iron Deficiency in Young Children Living in France
Assistance Publique - Hôpitaux de Paris 830
Not applicableStudy completedNCT01844349
What this trial is testing

Nutritional Transition in the Maghreb and Prevention of Obesity and Non-communicable Diseases

Who this might be right for
Iron Deficiency,Anaemia,Overweight,+1 more
Agnes GARTNER 8,218
Testing effectiveness (Phase 2)Looking for participantsNCT07249346
What this trial is testing

Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaMyelodysplasiaChronic Myelomonocytic Leukemia
Hannah Choe, MD 124
Testing effectiveness (Phase 2)Study completedNCT01229761
What this trial is testing

Study to Improve Survival Among HIV-Exposed Infants in Botswana

Who this might be right for
HIV InfectionsNeutropeniaAnemia
Harvard School of Public Health (HSPH) 3,724
Post-approval studies (Phase 4)Study completedNCT01084213
What this trial is testing

Intermittent Preventive Treatment Versus Scheduled Screening and Treatment of Malaria in Pregnancy

Who this might be right for
MalariaPregnancyAnaemia
London School of Hygiene and Tropical Medicine 5,354
Post-approval studies (Phase 4)Study completedNCT05980156
What this trial is testing

Comparing Chemoprevention Drugs for School-based Malaria Control

Who this might be right for
Malaria,FalciparumAnemia in Children
University of Maryland, Baltimore 646
Large-scale testing (Phase 3)Study completedNCT02560935
What this trial is testing

Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II

Who this might be right for
Sickle Cell DiseaseStroke
Vanderbilt University Medical Center 440
Testing effectiveness (Phase 2)WithdrawnNCT00081055
What this trial is testing

OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Mesoblast International Sàrl
Not applicableStudy completedNCT01561248
What this trial is testing

Study of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic Colitis

Who this might be right for
Hemolytic Uremic SyndromeHemorrhagic ColitisIntestinal Infectious Disease+1 more
Universitätsklinikum Hamburg-Eppendorf 33
Testing effectiveness (Phase 2)Study completedNCT01319448
What this trial is testing

Intermittent Preventive Treatment for Malaria in Patient With Sickle Cell Disease

Who this might be right for
MalariaSickle Cell Crisis
London School of Hygiene and Tropical Medicine 270
Testing effectiveness (Phase 2)Study completedNCT02220985
What this trial is testing

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Leukemia of Ambiguous Lineage+20 more
Fred Hutchinson Cancer Center 84
Not applicableStudy completedNCT05856357
What this trial is testing

Perennial Malaria Chemoprevention (PMC) in Côte d'Ivoire

Who this might be right for
MalariaAnemia
London School of Hygiene and Tropical Medicine 1,381
Very early researchActive Not RecruitingNCT05662098
What this trial is testing

Alternative Dosing And Prevention of Transfusions (ADAPT)

Who this might be right for
Sickle Cell Disease
Children's Hospital Medical Center, Cincinnati 100
Testing effectiveness (Phase 2)UnknownNCT00415727
What this trial is testing

Prevention Of Morbidity In Sickle Cell Disease Pilot Phase

Who this might be right for
Sickle Cell Anaemia
Institute of Child Health 22
Not applicableStudy completedNCT02610881
What this trial is testing

Acceptability and Feasibility of Micronutrient Powders Versus Iron Syrup for Anemia Prevention in Young Children

Who this might be right for
Anemia
Emory University 110
Large-scale testing (Phase 3)Study completedNCT05085275
What this trial is testing

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Who this might be right for
Anemia, Iron DeficiencyHyperphosphatemiaRenal Insufficiency, Chronic+4 more
USRC Kidney Research 289
Testing effectiveness (Phase 2)Looking for participantsNCT05089227
What this trial is testing

Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study

Who this might be right for
Prolonged AnticoagulationVenous Thromboembolic DiseaseAutoimmune Hemolytic Anemia
Centre Hospitalier Universitaire Dijon 72
Next Page